Endotoxin Content Testing in Biological Products with Recombinant Factor C

Main Article Content

Ekalak Songtan
Kanitta Phuwanartnaranubarn

Downloads

Download data is not yet available.

Article Details

Section
Review Article
Author Biographies

Ekalak Songtan, Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health

Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health, Tiwanon Road, Mueang District, Nonthaburi, 11000, Thailand

Kanitta Phuwanartnaranubarn, Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health

Institute of Biological Products, Department of Medical Sciences, Ministry of Public Health, Tiwanon Road, Mueang District, Nonthaburi, 11000, Thailand

References

Silveira RL, Andrade SS, Schmidt CA, Casali RG, Dalmora SL. Comparative evaluation of pyrogens tests in pharmaceutical products. Braz.J Microbiology 2004;35(1-2):48-53. doi: 10.1590/S1517-83822004000100007.

European Directorate for Quality of Medicine & Healthcare of the Council of Europe. European pharmacopoeia 10.0: bacterial endotoxins. Strasbourg: Council of Europe; 2019. p. 209-213.

European Directorate for Quality of Medicine & Healthcare of the Council of Europe. European pharmacopoeia 10.0: guidelines for using the test for bacterial endotoxins. Strasbourg: Council of Europe; 2019. p. 639-642.

U.S. Pharmacopoeia National Formulary. <85> Bacterial endotoxins test. In: USP43–NF38 [Internet]. 2012 [cited 2021 Mar 23]. Available from: https://www.usp.org/harmonization-standards/pdg/general-methods/bacterial-endotoxins

European Directorate for Quality of Medicine & Healthcare of the Council of Europe. European pharmacopoeia 10.3: Test for bacterial endotoxins using recombinant factor c. Strasbourg: Council of Europe; 2021. p. 4776-7.

Hartung T, Borel A, Schmitz G. Detecting the broad spectrum of pyrogens with the human whole-blood monocyte activation test [Internet]. NY: BioProcess International. 2016 [cited 2021 Mar 23]. 14(3):38-56. Available from: https://bioprocessintl.com/analytical/downstream-validation/detecting-the-broad-spectrum-of-pyrogens-with-the-human-whole-blood-monocyte-activation-test/

Sastalla I, Monack DM, Kubatzky KF. Bacterial exotoxins: how bacteria fight the immune system. Front. Immunology 2016;7:300. doi: 10.3389/fimmu.2016.00300.

Sandle T. Endotoxin and Pyrogen Testing. In pharmaceutical microbiology: essentials for quality assurance and quality control. New Delhi: Woodhead. 2015. p. 131-145.

Williams KL. Endotoxin detection and control in pharma, limulus, and mammalian systems. Springer: Cham; 2019. p. 95-155.

Albertus B, Lambertus GT. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. Journal of Endotoxin Research 2003;9(1):3-24. doi:10.1177/09680519030090010101.

Rangel-Frausto MS. The epidemiology of bacterial sepsis. Infect Dis Clin North Am 1999;13(2): 299-312. doi: 10.1016/s0891-5520(05)70076-3. PMID: 10340168.

Department of Health and Human Services. Guidance for industry pyrogen and endotoxins testing: questions and answers [Internet]. Washington DC: U.S. FDA; 2012 [cited 2021 Feb 13]. Available from: https://www.fda.gov/media/83477/download

European Medicines Agency. ICH guideline Q4B annex 14 to note for evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on bacterial endotoxins tests – general chapter [Internet]. London: EMA; 2013 [cited 2021 Feb 13]. Available from: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en.pdf

World Health Organization. 3.4 Test for bacterial endotoxins [Internet]. Geneva: WHO; 2012 [cited 2021 Feb 13]. Available from: https://www.who.int/medicines/publications/pharmacopoeia/Bacterial-endotoxins_QAS11-452_FINAL_July12.pdf

Dubczak J. Past, present, and future of endotoxin testing [Internet]. American Pharmaceutical Review; 2020 [cited 2021 Mar 23]; 23(7):40-43. Available from: https://www.americanpharmaceuticalreview.com/Featured-Articles/571720-Past-Present-and-Future-of-Endotoxin-Testing/

ฐิติพร ภาคภูมิพงศ์. การทดสอบสารไพโรเจน ในผลิตภัณฑ์ยาฉีดปราศจากเชื้อ. วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต 2011;21(1):37-40.

Gorman R. Atlantic horseshoe crabs and endotoxin testing: perspectives on alternatives, sustainable methods, & the 3Rs (replacement, reduction and refinement). Front. Mar. Sci. 2020;7:833. doi: 10.3389/fmars.2020.582132.

Krisfalusi GJ, Ali W, Dellinger K, Robertson L. The role of horseshoe crabs in the biomedical industry and recent trends impacting species sustainability. Front. Mar. Sci. 2018;5:185. doi: 10.3389/fmars.2018.00185.

Maloney T, Phelan R, Simmons N. Saving the horseshoe crab: A synthetic alternative to horseshoe crab blood for endotoxin detection. PLoS Biol. 2018;16(10):1-15. doi: 10.1371/journal.pbio.2006607.

Madrigal AC. The blood harvest [Internet]. Washington DC; The Atlantic; 2014 [cited 2021 Feb 24]. Available from: https://shapeoflife.org/sites/default/files/global/the-blood-harvest-technology-the-atlantic.pdf

Kocek AR. The narrow edge: a tiny bird, an ancient crab, and an epic journey. The Condor: Ornithological Applications 2018;(120):247-248. doi: 10.1650/CONDOR-17-228.1.

Chesler C. Medical labs may be killing horseshoe crabs. Scientific American [Internet]. 2016 [cited 2021 Feb 24]. Available from: https://www.scientificamerican.com/article/medical-labs-may-be-killing-horseshoe-crabs/

Zhang S. The last days of the blue-blood harvest [Internet]. Washington DC: The Atlantic; 2018 [cited 2021 Feb 24]. Available from: https://www.theatlantic.com/science/archive/2018/05/blood-in-the-water/559229/

Deborah C. Inside the biomedical revolution to save horseshoe crabs and the shorebirds that need them [Internet]. NY: Audubon; 2018 [cited 2021 Feb 24]. Available from: https://www.audubon.org/magazine/summer-2018/inside-biomedical-revolution-save-horseshoe-crabs

Rebecca LA, Winsor HW, Christopher CC. Sub-lethal behavioral and physiological effects of the biomedical bleeding process on the American horseshoe crab, limulus polyphemus. Bio Bull 2013;225(3):137-151. doi: 10.1086/BBLv225n3p137.

Russell WMS, Burch RL. The principles of humane experimental technique [Internet]. London: Methuen; 1959 [cited 2021 Feb 28]. Available from: https://caat.jhsph.edu/principles/the-principles-of-humane-experimental-technique

The European Union. Directive2010/63/ EU of The european parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes. Journal of the European Union [Internet]. 2010 [cited 2021 Mar 18]. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:en:PDF

Ding JL, Ho B. A new era in pyrogen testing. Trends in Biotechnol 2001 Aug;19(8):277-81. doi: 10.1016/s0167-7799(01)01694-8. PMID: 11451451.

Ding J, Ho B. Cloned factor C CDNA of the Singapore horseshoe crab, carcinoscorpius rotundicauda and purification of factor C proenzyme [Internet]. US Patent; 1998 No. 5712144 . [cited 2021 Mar 18]. Available from: https://patentimages.storage.googleapis.com/c0/d7/95/290092910d8823/US5712144.pdf

Piehler M, Roeder R, Blessing S, Reich J. Comparison of LAL and rFC assays participation in a proficiency test program between 2014 and 2019. Microorganisms 2020;8(3):418. doi: 10.3390/microorganisms8030418. PMID: 32188126; PMCID: PMC7143553.

Bolden J. Recombinant factor C in endotoxin detection and control in pharma, limulus, and mammalian systems. Springer: Cham; 2019. doi: 10.1007/978-3-030-17148-3_13.

Ding JL, Ho B. Endotoxin detection–from limulus amebocyte lysate to recombinant factor C. Subcell Biochem 2010;53:187-208. doi: 10.1007/978-90-481-9078-2_9. PMID: 20593268.

Alwis KU, Milton DK. Recombinant factor C assay for measuring endotoxin in house dust: comparison with LAL, and (1-->3)-beta-D-glucans. Am J Ind Med 2006 Apr;49(4):296-300. doi: 10.1002/ajim.20264. PMID: 16550568.

Chen L, Mozier N. Comparison of limulus amebocyte lysate test methods for endotoxin measurement in protein solutions. J Pharm Biomed Anal 2013Jun; 80:180-5. doi: 10.1016/j.jpba.2013.03.011. Epub 2013 Mar 26. PMID: 23584077.

Bolden J, Smith K. Application of recombinant factor C reagent for the detection of bacterial endotoxins in pharmaceutical products. PDA J Pharm Sci Technol 2017;71(5):405-412. doi: 10.5731/pdajpst.2017.007849. Epub 2017 Jul 20. PMID: 28733334.

Marius M, Vacher F, Bonnevay T. Comparison of LAL and recombinant factor C endotoxin testing assays in human vaccines with complex matrices. PDA J Pharm Sci Technol 2020;74(4):394-407. doi: 10.5731/pdajpst.2019.010389. Epub 2020 Mar 16. PMID: 32179709.

Marius M, Vacher, F, Bonnevay T. Comparison of bacterial endotoxin testing methods in purified pharmaceutical water matrices. Biologicals 2020 Sep;67:49-55. doi: 10.1016/j.biologicals.2020.07.001. Epub 2020 Aug 2. PMID: 32753293.

Dubczak J, Reid N, Tsuchiya M. Evaluation of limulus amebocyte lysate and recombinant endotoxin alternative assays for an assessment of endotoxin detection specificity. Eur J Pharm Sci 2021 Apr 1;159:105716. doi: 10.1016/j.ejps.2021.105716. Epub 2021 Jan 14.

Council of Europe. Recombinant factor C: new Ph. Eur. chapter available as of 1 July 2020 [Internet]. Strabourg: Council of Europe; 2020 [cited 2021 Mar 23] Available from: https://www.edqm.eu/en/news/recombinant-factor-c-new-ph-eur-chapter-available-1-july-2020

Bolden J, Knutsen C, Levin J, Milne C, Morris T, Mozier N, von Wintzingerode F. Currently available recombinant alternatives to horseshoe crab blood lysates: are they comparable for the detection of environmental bacterial endotoxins? a review. PDA J Pharm Sci Technol 2020;74(5):602-611. doi: 10.5731/pdajpst.2020.012187. Epub 2020 Aug 14. PMID: 32817324.

U.S. Pharmacopoeia National Formulary. USP provides guidelines for recombinant factor C (rFC) a non-animal-derived reagent critical to development of vaccines and other sterile pharmaceutical products [Internet]. MD: US Prarmacopeial Convention; 2020 [cited 2021 Mar 23] Available from: https://www.usp.org/news/rfc-horseshoe-crabs-statement

Loverock B, Simon B, Burgenson A, Baines A. A recombinant factor C procedure for the detection of gram-negative bacterial endotoxin. Pharmacopeial Forum 2010;36(1):321-329.

Pharmaceuticals and Medical Devices Agency. Japanese Pharmacopeia: bacterial endotoxins test and alternative methods using recombinant protein-reagents for endotoxin assay [Internet]. 2019 [cited 2021 Mar 23]. Available from: https://www.pmda.go.jp/files/000231653.pdf

European Directorate for Quality of Medicine & Healthcare of the Council of Europe. European Pharmacopoeia 10.0: 2.6.30 monocyte activation test. Strasbourg: Council of Europe; 2019. p. 233-39.